Patents by Inventor Michael L. Vieira

Michael L. Vieira has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SUSTAINED-RELEASE FORMULATIONS OF TOPIRAMATE
    Publication number: 20160022596
    Abstract: Pharmaceutical compositions of topiramate for once-a-day oral administration are provided. The formulations comprise a sustained-release component and an optional immediate-release component, the compositions of which can be selectively adjusted, respectively, to release the active ingredient along a pre-determined release profile. Method of treating or preventing pathological disorders in mammalian subjects comprising the administration of the novel formulations disclosed herein is also provided.
    Type: Application
    Filed: February 24, 2015
    Publication date: January 28, 2016
    Applicant: Supernus Pharmaceuticals, Inc.
    Inventors: Likan Liang, Hua WANG, Padmanabh P. BHATT, Michael L. VIEIRA
  • Sustained-release formulations of topiramate
    Patent number: 8992989
    Abstract: Pharmaceutical compositions of topiramate for once-a-day oral administration are provided. The formulations comprise a sustained-release component and an optional immediate-release component, the compositions of which can be selectively adjusted, respectively, to release the active ingredient along a pre-determined release profile. Method of treating or preventing pathological disorders in mammalian subjects comprising the administration of the novel formulations disclosed herein is also provided.
    Type: Grant
    Filed: September 29, 2014
    Date of Patent: March 31, 2015
    Assignee: Supernus Pharmaceuticals, Inc.
    Inventors: Likan Liang, Hua Wang, Padmanabh P. Bhatt, Michael L. Vieira
  • STABILIZED FORMULATIONS OF CNS COMPOUNDS
    Publication number: 20150086629
    Abstract: Formulations of molindone having superior stability and methods of administering same are provided. The formulations may be immediate, modified, or otherwise delayed release formulations of molindone.
    Type: Application
    Filed: April 25, 2014
    Publication date: March 26, 2015
    Applicant: Supernus Pharmaceuticals, Inc.
    Inventors: Rong-Kun Chang, Michael L. Vieira, Likan LIANG, Padmanabh P. BHATT, Austin B. HUANG, Sachin V. PATEL
  • SUSTAINED-RELEASE FORMULATIONS OF TOPIRAMATE
    Publication number: 20150017249
    Abstract: Pharmaceutical compositions of topiramate for once-a-day oral administration are provided. The formulations comprise a sustained-release component and an optional immediate-release component, the compositions of which can be selectively adjusted, respectively, to release the active ingredient along a pre-determined release profile. Method of treating or preventing pathological disorders in mammalian subjects comprising the administration of the novel formulations disclosed herein is also provided.
    Type: Application
    Filed: September 29, 2014
    Publication date: January 15, 2015
    Applicant: Supernus Pharmaceuticals, Inc.
    Inventors: Likan Liang, Hua WANG, Padmanabh P. BHATT, Michael L. VIEIRA
  • Sustained-release formulations of topiramate
    Patent number: 8889191
    Abstract: Pharmaceutical compositions of topiramate for once-a-day oral administration are provided. The formulations comprise a sustained-release component and an optional immediate-release component, the compositions of which can be selectively adjusted, respectively, to release the active ingredient along a pre-determined release profile. Method of treating or preventing pathological disorders in mammalian subjects comprising the administration of the novel formulations disclosed herein is also provided.
    Type: Grant
    Filed: December 17, 2010
    Date of Patent: November 18, 2014
    Assignee: Supernus Pharmaceuticals, Inc.
    Inventors: Likan Liang, Hua Wang, Padmanabh P. Bhatt, Michael L. Vieira
  • Sustained-release formulations of topiramate
    Patent number: 8877248
    Abstract: Pharmaceutical compositions of topiramate for once-a-day oral administration are provided. The formulations comprise a sustained-release component and an optional immediate-release component, the compositions of which can be selectively adjusted, respectively, to release the active ingredient along a pre-determined release profile. Method of treating or preventing pathological disorders in mammalian subjects comprising the administration of the novel formulations disclosed herein is also provided.
    Type: Grant
    Filed: July 14, 2014
    Date of Patent: November 4, 2014
    Assignee: Supernus Pharmaceuticals, Inc.
    Inventors: Likan Liang, Hua Wang, Padmanabh P. Bhatt, Michael L. Vieira
  • SUSTAINED-RELEASE FORMULATIONS OF TOPIRAMATE
    Publication number: 20140322343
    Abstract: Pharmaceutical compositions of topiramate for once-a-day oral administration are provided. The formulations comprise a sustained-release component and an optional immediate-release component, the compositions of which can be selectively adjusted, respectively, to release the active ingredient along a pre-determined release profile. Method of treating or preventing pathological disorders in mammalian subjects comprising the administration of the novel formulations disclosed herein is also provided.
    Type: Application
    Filed: July 14, 2014
    Publication date: October 30, 2014
    Inventors: Likan Liang, Hua Wang, Padmanabh P. Bhatt, Michael L. Vieira
  • Stabilized formulations of CNS compounds
    Patent number: 8748472
    Abstract: Formulations of molindone having superior stability and methods of administering same are provided. The formulations may be immediate, modified, or otherwise delayed release formulations of molindone.
    Type: Grant
    Filed: March 30, 2011
    Date of Patent: June 10, 2014
    Assignee: Supernus Pharmaceuticals, Inc.
    Inventors: Rong-Kun Chang, Michael L. Vieira, Likan Liang, Padmanabh P. Bhatt, Austin B. Huang, Sachin V. Patel
  • Sustained-release formulations of topiramate
    Patent number: 8663683
    Abstract: Pharmaceutical compositions of topiramate for once-a-day oral administration are provided. The formulations comprise a sustained-release component and an optional immediate-release component, the compositions of which can be selectively adjusted, respectively, to release the active ingredient along a pre-determined release profile. Method of treating or preventing pathological disorders in mammalian subjects comprising the administration of the novel formulations disclosed herein is also provided.
    Type: Grant
    Filed: August 27, 2012
    Date of Patent: March 4, 2014
    Assignee: Supernus Pharmaceuticals, Inc.
    Inventors: Likan Liang, Hua Wang, Padmanabh P. Bhatt, Michael L. Vieira
  • SUSTAINED-RELEASE FORMULATIONS OF TOPIRAMATE
    Publication number: 20120321708
    Abstract: Pharmaceutical compositions of topiramate for once-a-day oral administration are provided. The formulations comprise a sustained-release component and an optional immediate-release component, the compositions of which can be selectively adjusted, respectively, to release the active ingredient along a pre-determined release profile. Method of treating or preventing pathological disorders in mammalian subjects comprising the administration of the novel formulations disclosed herein is also provided.
    Type: Application
    Filed: August 27, 2012
    Publication date: December 20, 2012
    Inventors: Likan Liang, Hua Wang, Padmanabh P. Bhatt, Michael L. Vieira
  • Sustained-release formulations of topiramate
    Patent number: 8298576
    Abstract: Pharmaceutical compositions of topiramate for once-a-day oral administration are provided. The formulations comprise a sustained-release component and an optional immediate-release component, the compositions of which can be selectively adjusted, respectively, to release the active ingredient along a pre-determined release profile. Method of treating or preventing pathological disorders in mammalian subjects comprising the administration of the novel formulations disclosed herein is also provided.
    Type: Grant
    Filed: November 16, 2007
    Date of Patent: October 30, 2012
    Assignee: Supernus Pharmaceuticals, Inc.
    Inventors: Likan Liang, Hua Wang, Padmanabh P. Bhatt, Michael L. Vieira
  • Sustained-release formulations of topiramate
    Patent number: 8298580
    Abstract: Pharmaceutical compositions of topiramate for once-a-day oral administration are provided. The formulations comprise a sustained-release component and an optional immediate-release component, the compositions of which can be selectively adjusted, respectively, to release the active ingredient along a pre-determined release profile. Method of treating or preventing pathological disorders in mammalian subjects comprising the administration of the novel formulations disclosed herein is also provided.
    Type: Grant
    Filed: December 17, 2010
    Date of Patent: October 30, 2012
    Assignee: Supernus Pharmaceuticals, Inc.
    Inventors: Likan Liang, Hua Wang, Padmanabh P. Bhatt, Michael L. Vieira
  • Sustained-release formulations of topiramate
    Publication number: 20110287099
    Abstract: Pharmaceutical compositions of topiramate for once-a-day oral administration are provided. The formulations comprise a sustained-release component and an optional immediate-release component, the compositions of which can be selectively adjusted, respectively, to release the active ingredient along a pre-determined release profile. Method of treating or preventing pathological disorders in mammalian subjects comprising the administration of the novel formulations disclosed herein is also provided.
    Type: Application
    Filed: December 17, 2010
    Publication date: November 24, 2011
    Inventors: Likan Liang, Hua Wang, Padmanabh P. Bhatt, Michael L. Vieira
  • Sustained-release formulations of topiramate
    Publication number: 20110287103
    Abstract: Pharmaceutical compositions of topiramate for once-a-day oral administration are provided. The formulations comprise a sustained-release component and an optional immediate-release component, the compositions of which can be selectively adjusted, respectively, to release the active ingredient along a pre-determined release profile. Method of treating or preventing pathological disorders in mammalian subjects comprising the administration of the novel formulations disclosed herein is also provided.
    Type: Application
    Filed: December 17, 2010
    Publication date: November 24, 2011
    Inventors: Likan Liang, Hua Wang, Padmanabh P. Bhatt, Michael L. Vieira
  • STABILIZED FORMULATIONS OF CNS COMPOUNDS
    Publication number: 20110244042
    Abstract: Formulations of molindone having superior stability and methods of administering same are provided. The formulations may be immediate, modified, or otherwise delayed release formulations of molindone.
    Type: Application
    Filed: March 30, 2011
    Publication date: October 6, 2011
    Inventors: Rong-Kun CHANG, Michael L. Vieira, Likan Liang, Padmanabh P. Bhatt, Austin B. Huang, Sachin V. Patel
  • METHOD OF TREATMENT OF A NEUROLOGICAL DISORDER
    Publication number: 20110003870
    Abstract: A method of treating neurological conditions, such as Parkinson's Disease and Restless Leg Syndrome, in a mammalian subject is disclosed. The method comprises the administration of a once-a-day controlled release formulation of pramipexole, which formulation provides a consistently ascending PK profile during sleeping hours.
    Type: Application
    Filed: June 30, 2010
    Publication date: January 6, 2011
    Inventors: Michael L. Vieira, Jones Woodrow Bryan, JR.
  • CONTROLLED RELEASE FORMULATIONS OF PRAMIPEXOLE
    Publication number: 20090304794
    Abstract: A controlled release formulation of pramipexole for once-a-day administration to a mammalian subject, which formulation releases pramipexole along a pre-determined release profile, is provided.
    Type: Application
    Filed: June 5, 2009
    Publication date: December 10, 2009
    Inventors: Michael L. Vieira, Padmanabh P. Bhatt, Austin B. Huang
  • CONTROLLED RELEASE FORMULATIONS OF ALPRAZOLAM
    Publication number: 20090280176
    Abstract: A controlled release formulation of alprazolam for once a day administration to a mammalian subject, which formulation releases alprazolam along a pre-determined release profile, is provided.
    Type: Application
    Filed: May 7, 2009
    Publication date: November 12, 2009
    Inventors: Michael L. Vieira, Padmanabh P. Bhatt
  • SUSTAINED-RELEASE FORMULATIONS OF TOPIRAMATE
    Publication number: 20080118557
    Abstract: Pharmaceutical compositions of topiramate for once-a-day oral administration are provided. The formulations comprise a sustained-release component and an optional immediate-release component, the compositions of which can be selectively adjusted, respectively, to release the active ingredient along a pre-determined release profile. Method of treating or preventing pathological disorders in mammalian subjects comprising the administration of the novel formulations disclosed herein is also provided.
    Type: Application
    Filed: November 16, 2007
    Publication date: May 22, 2008
    Inventors: Likan Liang, Hua Wang, Padmanabh P. Bhatt, Michael L. Vieira